abstract |
Methods are provided for stimulating or inhibiting monocyte activity using OPG ligands, or other agonists or antagonists. Further provided is a method of treating a disease state, particularly a condition related to immunity, using such an OPG ligand, agonist or antagonist. Agonists and antagonists contemplated for use in the present invention include anti-RANK receptor antibodies, anti-OPG ligand antibodies, anti-OPG receptor antibodies, RANK receptor immunoadhesins, and OPG receptor immunoadhesins. |